Clinical Trial Update: Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated oral estramustine and oral vinorelbine in patients with hormone-refractory prostate cancer. The study was conduct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Estramustine (Estracyt) (estramustine)
• Vinorelbine tartrate (Navelbine) (vinorelbine)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED